Sort
4,870 grants matching “glp 1”
Improving beta-cell function in Mexican American women with prediabetes
$375,670Willa A. Hsueh · Ohio State University · R01 · FY2016 · MD
Pharmaceutical and Regulatory Core
$375,668David R Friend · Magee-Women'S Res Inst And Foundation · U19 · FY2013 · AI
PROLIFERATIVE VS MEIOTIC FATE DECISION IN C. ELEGANS
$375,150Tim B. Schedl · Washington University · R01 · FY2016 · GM
PROLIFERATIVE VS MEIOTIC FATE DECISION IN C. ELEGANS
$375,150Tim B. Schedl · Washington University · R01 · FY2019 · GM
PROLIFERATIVE VS MEIOTIC FATE DECISION IN C. ELEGANS
$375,150Tim B. Schedl · Washington University · R01 · FY2017 · GM
Neural mechanisms of nausea, vomiting, and energy balance dysregulation in animal models
$374,398Bart C De Jonghe · University Of Pennsylvania · R01 · FY2017 · DK
GLP-1 to Enhance Islet Transplantation
$374,300Vanderbilt University · R21 · FY2003 · DK
Ancillary Study Proposal for The Restoring Insulin Secretion (RISE) Study: Autoimmune Mechanisms for the Progressive Decline of Beta cell Function in Type 2 Diabetes (T2D)
$374,287Jerry P Palmer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2017 · DK
Improving beta-cell function in Mexican American women with prediabetes
$373,495Willa A. Hsueh · Ohio State University · R01 · FY2015 · MD
Mechanisms and Therapeutic Targeting of Chronic Neuroinflammation in Traumatic Brain Injury
$373,450Darrell W Brann · Augusta University · R01 · FY2024 · NS
Mechanisms Underlying Predictors of Success from Obesity Surgery
$373,096Harry R Kissileff · Columbia University Health Sciences · R01 · FY2015 · DK
The role of GLP-1 in normal and abnormal glucose tolerance
$373,032David A. D'alessio · University Of Cincinnati · R01 · FY2010 · DK
Core 4: Regulatory Compliance
$372,529Ronald B Corley · Boston University Medical Campus · UC7 · FY2022 · AI
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands
$372,500Ravikumar N Majeti · University Of Alabama In Tuscaloosa · R01 · FY2021 · DK
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands
$372,500Ravikumar N Majeti · University Of Alabama In Tuscaloosa · R01 · FY2022 · DK
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands
$372,500Ravikumar N Majeti · University Of Alabama In Tuscaloosa · R01 · FY2023 · DK
Comparison of Tirzepatide, Retatrutide, and Crocetin, for Mitigation of Alzheimer's-like Pathology in a Mouse Model of Alzheimerâs Disease
$372,400Robert Charles Speth · Nova Southeastern University · R15 · FY2025 · AG
Project 1 - Defining the structure and function of NTS satiety circuits
$372,187Martin G Myers · University Of Michigan At Ann Arbor · P01 · FY2019 · DK
Project 3: Neural mediators in the metabolic effects of Vertical Sleeve Gastrectomy
$372,185Darleen A Sandoval · University Of Michigan At Ann Arbor · P01 · FY2019 · DK
Project 2: Regulation, circuitry, and function of non-aversive and aversive PBN satiety systems
$372,185David P Olson · University Of Michigan At Ann Arbor · P01 · FY2019 · DK
Predictors of Weight Loss and Weight Loss Maintenance to Lifestyle Modification Therapy and Pharmacotherapy for Adolescents with Obesity
$371,899Amy C. Gross · University Of Minnesota · R01 · FY2023 · DK
Predictors of Weight Loss and Weight Loss Maintenance to Lifestyle Modification Therapy and Pharmacotherapy for Adolescents with Obesity
$371,899Amy C. Gross · University Of Minnesota · R01 · FY2025 · DK
Core B
$371,578Patrick Concannon · University Of Florida · P01 · FY2019 · AI
A Novel Pharmacologic Approach to Treat CMT1X
$371,450Rick T Dobrowsky · University Of Kansas Lawrence · R33 · FY2022 · NS
PEDIATRIC PHARMACOLOGY RESEARCH UNIT
$371,253Louisiana State Univ Hsc Shreveport · U01 · FY2001 · HD